Riskpilot← Back to searchSign inGet full accessSTEKKE LEGESENTER AS
ASActiveOrg 896901532Fløytarvegen 3B, 7650 VerdalGeneral medical practice activities · NACE 8621Est. 201116 employees
Revenue 2025
NOK 5,3M
+2% vs 2024
EBITDA margin
6.3%
-35% vs 2024
Equity ratio
11.5%
Financial strength
Net profit 2025
NOK 246K
-37% vs 2024
| Revenue | NOK 5,3M | +2% |
| EBITDA | NOK 334K | -35% |
| Net profit | NOK 246K | -37% |
| Total assets | NOK 1,1M | -20% |
| Equity | NOK 123K | -56% |
| Employees | 16 | — |
Legal name
STEKKE LEGESENTER AS
Org number
896901532
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
9. mai 2011
Share capital
NOK 102 000
Employees
16 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legesenter, helsetjenester, informasjon og salg samt deltagelse i selskaper av samme eller annen art gjennom aksjetegning eller på annen måte.
Address
Fløytarvegen 3B, 7650 Verdal
Phone
+4799589200
Email
guri.holmvik@stekkelegesenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 064 | 4 924 | 5 069 | 5 178 | 5 276 |
| Staff expenses | −1 850 | −2 066 | −2 069 | −1 985 | −2 129 |
| EBITDA | −17 | 63 | 194 | 518 | 334 |
| Depreciation & amort. | −15 | −15 | −15 | −12 | −14 |
| EBIT | −32 | 49 | 179 | 506 | 320 |
| Net financials | −0 | 0 | 0 | −0 | −2 |
| Profit before tax | −32 | 49 | 179 | 506 | 318 |
| Tax | −7 | 11 | 32 | 115 | 71 |
| Net profit | −25 | 38 | 147 | 391 | 246 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 556 | 681 | 759 | 1 325 | 1 066 |
| Equity | 101 | 139 | 286 | 277 | 123 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 455 | 542 | 473 | 1 049 | 943 |
| Total debt | 455 | 542 | 473 | 1 049 | 943 |
EBITDA margin
6.3%
This company
15.8%
Market median
-60% vs market
20212025
Equity ratio
11.5%
This company
38.2%
Market median
-70% vs market
20212025
Return on equity
200.4%
This company
18.4%
Market median
+989% vs market
20212025
Net profit margin
4.7%
This company
8.1%
Market median
-42% vs market
20212025
Asset turnover
4.95×
This company
1.12×
Market median
+342% vs market
20212025
Debt / equity
7.67×
This company
0.62×
Market median
-1137% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GH Chief Executive Officer | Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of STEKKE LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Guri Holmvik | Chief Executive Officer | 0 companies |
| Lene Marit Ness-Jensen | Chairman | 0 companies |